S. Si-Ahmed

Safety and efficacy of intra-arterial hepatic chemotherapy with doxorubicin-loaded nanoparticles in hepatocellular carcinoma

P. Couzigou, J. Taieb, P. Merle, 2017, ESMO Open.

Impact of lamivudine-resistance mutations on entecavir treatment outcome in hepatitis B

F. Zoulim, P. Pradat, F. Bailly, 2014, European journal of gastroenterology & hepatology.

Efficacy and tolerance of a combination of tenofovir disoproxil fumarate plus emtricitabine in patients with chronic hepatitis B: a European multicenter study.

M. Buti, F. Zoulim, J. Dumortier, 2011, Antiviral research.

Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: a multicenter experience.

D. Samuel, J. Dumortier, O. Guillaud, 2014, Journal of hepatology.

Epidemiology of chronic hepatitis B infection in France: risk factors for significant fibrosis – results of a nationwide survey

X. Causse, T. Fontanges, P. Hervio, 2007, Alimentary pharmacology & therapeutics.

Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon

G. Colucci, C. Trépo, F. Bailly, 1997, Journal of medical virology.

FIG4 is a hepatitis C virus particle-bound protein implicated in virion morphogenesis and infectivity with cholesteryl ester modulation potential.

F. Zoulim, S. Clément, S. Pitteri, 2016, The Journal of general virology.

47 EFFICACY AND SAFETY OF PROTEASE INHIBITORS FOR SEVERE HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION: A FIRST MULTICENTRIC EXPERIENCE

D. Samuel, B. Roche, A. Coilly, 2012 .